Clinical [2] and experimental [3] results indicate that diabetes is characterized by the up-regulation of both systemic and local angiotensin II (Ang II), and interventions targeting Ang II ameliorates the pathological changes of DCM. The gene discussed is AGT; the disease is diabetes mellitus.